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Abstract
Aims: To study circulating levels and distribution of adi-
ponectin multimers wlow molecular weight (LMW)-, medi-
um molecular weight (MMW)- and high molecular weight
(HMW)-adiponectinx in preterm and full-term infants.
Methods: Total serum adiponectin and its multimers
were measured in 40 healthy infants at the age of one
month and associations with anthropometric parameters
wbody weight and length, body mass index (BMI)x, weight
gain and metabolic indices (glucose, insulin) were exam-
ined. Twenty of the infants were born preterm (gestational
age 33.2"1.6 weeks).
Results: LMW-adiponectin level and its fractional ratio to
total adiponectin were significantly higher in full-term
than in preterm infants (P-0.001 and P-0.01, respec-
tively), whereas, MMW-adiponectin level and its ratio
were significantly lower (Ps0.03 and Ps0.01, respec-
tively). HMW-adiponectin did not differ significantly
between full-term and preterm infants and accounted for
almost 60% of total adiponectin levels in both groups.
HMW-adiponectin, but not MMW adiponectin or LMW
adiponectin, correlated significantly with anthropometric
measurements, similarly to total adiponectin; in addition,
HMW adiponectin correlated significantly with weight
gain.
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Conclusions: HMW adiponectin is the most prevalent
form in infants. Circulating levels and distribution of
MMW- and LMW-adiponectin differ between full-term
and preterm infants, but the role of these adiponectin
multimers needs to be studied further.
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Introduction
Adiponectin, an adipocytokine with profound insulin-sen-
sitizing effects and important role in regulating systemic
energy metabolism w15x, circulates in human blood as
multimers with distinct molecular sizes: trimeric low
molecular weight (LMW)-adiponectin, hexameric medium
molecular weight (MMW)-adiponectin, and high molecu-
lar weight (HMW)-adiponectin w33x. It has been suggest-
ed that adiponectin complexes have different biological
activities w23, 33x, but their specific properties are not yet
fully understood. Studies in adults and obese children
indicated that HMW-adiponectin is the major active form
of this adipokine w2, 3, 9x.
A great body of evidence suggests that circulating
levels of total adiponectin (composed of the sum of adi-
ponectin complexes), are much higher in neonates and
infants than levels in children and adults w16, 24x. Yet,
numerous previous studies have documented positive
correlations between total adiponectin levels and neo-
natal anthropometric indices w16, 24, 28, 30, 32x. Thus,
it has been strongly suggested that adiponectin has a
role in fetal and neonatal growth. However, the adipo-
nectin complexes in neonates have not been studied
extensively. Circulating HMW-adiponectin has been eval-
uated almost exclusively in cord blood of full-term new-
borns w10, 12, 13, 21x, whereas limited knowledge exists
regarding MMW-adiponectin and LMW-adiponectin in
either preterm or full-term infants w35x.
The aim of the present study was to determine the
circulating concentrations and distribution of adiponectin
complexes in preterm and full-term infants and to exam-
ine their possible associations with anthropometric para-
meters, weight gain and serum levels of glucose and
insulin.
Materials and methods
The study population consisted of 40 healthy infants (20 full-
term and 20 preterm infants with similar gender distribution) who
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met the following criteria: (1) mothers with uncomplicated preg-
nancy (without gestational diabetes mellitus, thyroid disease,
pregnancy-induced hypertension or autoimmune diseases) who
had elected formula feeding, (2) no neonatal morbidity (without
respiratory distress syndrome, hypotension, intraventricular
hemorrhage, necrotizing enterocolitis, sepsis) or congenital mal-
formation, and (3) tolerance of full enteral feeding the first day
of life for full-term infants and up to the 7th day of life for preterm
infants. Gestational age was estimated from the last menstrual
period and confirmed by fetal ultrasound measurements and
clinical examination of the neonate according to the new Ballard
score w4x.
Anthropometric measurements were recorded periodically in
all the infants by the same investigator. In preterm infants, body
weight was obtained daily using a standard electronic scale.
Recumbent length and head circumference were measured
weekly using a standardized length board and a non-stretchable
plastic insertion tape, respectively. In full-term infants, body
weight and length and head circumference were measured
weekly by the same method applied to preterm infants. Weight
gain in g/kg/day was estimated weekly in all infants. In addition,
body weight Z-scores wstandard deviation (SD) scores from the
mean after adjustment for gestational age and genderx were
evaluated at the end of the first month of age as described
previously w29x.
All infants underwent a venipuncture in the morning and
before feeding at the end of the first month of age for collection
of routine blood tests, as well as for determining total adipo-
nectin and its multimers (HMW-, MMW- and LMW-adiponectin),
glucose and insulin in serum.
The study protocol was approved by the Ethics Committee of
‘‘Aghia Sophia’’ Children’s Hospital and informed parental con-
sent was also obtained for all infants.
Total adiponectin, HMW-, MMW-, and LMW-adiponectin lev-
els were determined by a sandwich enzyme-linked immuno-
sorbent assay (ELISA) using a commercially available multimeric
adiponectin kit (Buehlmann Laboratories AG, Switzerland, pro-
duced by Daiichi Pure Chemicals Co, Ltd, Tokyo, Japan). Details
of the assay have been described previously w8x. The specific
antibodies used in this kit were monoclonal anti-human adipo-
nectin antibodies directed to two independent epitopes. For total
adiponectin determination, specimens were treated with sodium
dodecyl sulphate (SDS)-containing acid buffer to convert multi-
meric adiponectin to dimmeric and monomeric forms that were
assayed directly on the plate. To measure the HMW-, MMW-,
and LMW-adiponectin separately, samples were enzyme pre-
treated with two proteases, according to manufacturer instruc-
tions. For the HMW-adiponectin determination, protease II that
selectively digests LMW- and MMW-adiponectin was used and
the remaining HMW-adiponectin fraction was treated with SDS-
containing acid buffer to convert it mainly to dimmeric and
monomeric forms that were assayed directly on the plate w8x.
Protease I that selectively digests only the LMW-adiponectin
was used for MMWqHMW-adiponectin determination w8x. The
concentrations of MMW- and LMW-adiponectin were obtained
by subtracting the HMW concentration from the MMWqHMW
concentrations and the MMWqHMW concentrations from the
total adiponectin concentration, respectively. The intra-assay
precision coefficients of variation (CVs) for total-, HMW-, and
MMWqHMW-adiponectin were -5.4%, 5.0% and 5.0%,
respectively, and the inter-assay CVs were -5.0%, 5.7% and
6%, respectively, at different adiponectin levels, according to the
commercially available kit. The limit of sensitivity of the assay
was -0.08 ng/mL.
Serum glucose was assessed by an enzymatic glucose
oxidase method and the determination was performed using the
Siemens Advia 1800 Clinical Chemistry System (Siemens
Healthcare Diagnostics, Erlangen, Germany). The intra- and
inter-assay CVs were -0.9% and -1.5%, respectively. Serum
insulin concentrations were assessed by an electrochemilumi-
nesce immunoassay using the automated analyzer Cobas e 411
(Roche Diagnostics GmbH, Mannheim, Germany). This assay for
insulin determination employs two monoclonal antibodies which
together are specific for human insulin. The intra- and inter-
assay CVs did not exceed 2% and 2.8%, respectively.
Data are presented as mean (SD), apart from insulin concen-
trations expressed as median (25th–75th percentiles) because of
a non-normal distribution. Groups were compared for quantita-
tive variables by the Student-t or Mann-Whitney U-test, as
appropriate. Values of adiponectin multimers were normally dis-
tributed, both overall and for preterm and full-term infants sep-
arately. Correlation analyses were used to examine relations
among the variables of interest. Statistical significance was set
at P-0.05. All statistical analyses were performed using the
SPSS statistical package (SPSS, version 12.0, Chicago, IL).
Results
Demographic characteristics, anthropometric and growth
measurements of the study population are shown in
Table 1. Mean (SD) serum glucose concentrations were
significantly higher in full-term w4.9 (0.6) mmol/Lx than in
preterm infants w3.9 (0.8) mmol/L, P-0.01x. Median
(25th–75th percentiles) insulin concentrations were also
higher in full-term w6.9 (4.1–12.1) mU/Lx than in preterm
infants w2.8 (1.2–15.2) mU/L, P-0.05x.
Serum levels of total- and LMW-adiponectin were sig-
nificantly higher in full-term w46.6 (13.2) mg/mL and 11.7
(7.1) mg/mL, respectivelyx than in preterm infants w38.1
(11.2) mg/mL; Ps0.03 and 3.0 (2.5) mg/mL; P-0.001,
respectivelyx, whereas, levels of MMW-adiponectin were
lower w6.3 (4.5) mg/mL in full-term and 10.5 (7.4) mg/mL
in preterm infants; Ps0.03x. No difference was found in
HMW-adiponectin levels between full-term and preterm
infants w28.9 (10.3) mg/mL and 25.0 (7.2) mg/mL, respec-
tivelyx. In addition, the fractional HMW-adiponectin rela-
tive to total-adiponectin levels did not differ significantly
between full-term and preterm infants (Figure 1). How-
ever, the ratio of MMW-adiponectin to total-adiponectin
was lower in full-term than in preterm infants (Ps0.01),
whereas the ratio of LMW-adiponectin to total adiponec-
tin level was significantly higher (P-0.01) (Figure 1).
There was no difference both in absolute values of adi-
ponectin multimers and in their ratios to the total-adi-
ponectin value between sexes in full-term and preterm
infants.
HMW-adiponectin levels correlated significantly with
total-adiponectin levels in both full-term (rs0.87,
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Table 1 Characteristics of preterm and full-term infants.
Preterm infants Full-term infants
(ns20) (ns20)
Gestational age 33.2 (1.6) 39.1 (1.2)**
Birthweight 1646 (280) 3269 (334)**
Males/females 11/9 11/9
Data of studied groups when blood samples were drawn
Postnatal age, days 26.0 (5.7) 27.3 (4.9)
Body weight, g 2172 (190) 4148 (441)**
Body weight Z-score –1.5 (0.7) 1.2 (0.8)**
Body length, cm 46.6 (1.8) 55.4 (2.9)**
Head circumference, cm 32.7 (1.3) 36.7 (1.0)**
BMI, kg/m2 10.0 (0.8) 13.5 (1.0)**
Weight gain, g/kg/day (last week of study) 15.5 (3.7) 10.5 (4.5)**
All the data except for gender represent the mean (SD). BMIsbody mass index. **Compared with preterm infants; **PF0.01.
Figure 1 Boxplots showing the fractional ratios of serum adi-
ponectin multimers to total adiponectin in full-term (white boxes)
and preterm infants (shaded boxes). Boxes represent the inter-
quartile range; lines inside boxes represent the median value;
whiskers represent the lowest and highest observations, respec-
tively. Tstotal adiponectin, HsHMW-adiponectin, MsMMW-
adiponectin, LsLMW-adiponectin.
Table 2 Correlations between total-adiponectin or HMW-adiponectin levels and anthropometric measurements and weight gain in
infants studied.
Entire study population Preterm infants Full-term infants
(ns40) (ns20) (ns20)
vs. Total vs. HMW vs. Total vs. HMW vs. Total vs. HMW
Birthweight 0.46** 0.36* 0.67** 0.68** n.s. n.s.
Body weight 0.38* 0.33* 0.52* 0.77** n.s. n.s.
Body weight Z-score 0.47** 0.36* 0.66** 0.61** n.s. n.s.
BMI 0.46** 0.40* 0.60* 0.69** 0.78† 0.58*
Weight gain n.s. 0.37** n.s. 0.64** n.s. 0.67†
HMWshigh molecular weight, BMIsbody mass index, n.s.snot significant, *P-0.05, **PF0.01, †PF0.001.
P-0.001) and preterm infants (rs0.77, P-0.001). A sig-
nificant correlation between MMW-adiponectin and total-
adiponectin levels was observed in preterm infants only
(rs0.93, P-0.001), whereas, LMW-adiponectin correlat-
ed significantly with total-adiponectin levels in full-term
infants only (rs0.67, Ps0.001).
In the total study population, HMW-adiponectin levels
correlated significantly with birth weight and anthropo-
metric measurements when blood samples were drawn,
including body weight, body weight Z-score and body
mass index (BMI), similarly to total adiponectin (Table 2).
In addition, HMW-adiponectin levels correlated signifi-
cantly with the infants’ weight gain, whereas, a non-sig-
nificant correlation was recorded between total adi-
ponectin and weight gain (Ps0.08). As shown in Table
2, HMW-adiponectin presented all the significant asso-
ciations observed between total adiponectin and
variables studied in preterm and full-term infants sepa-
rately. MMW-adiponectin and LMW-adiponectin did not
correlate significantly with anthropometric measurements
or weight gain in the total study population or in the
groups of full-term and preterm infants. No significant
correlation was also recorded between total adiponectin
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or any of the adiponectin complexes and glucose or
insulin concentrations.
Discussion
According to the results of this study, there are some
differences in level and distribution of adiponectin com-
plexes between full-term and preterm infants. The cir-
culating levels of MMW-adiponectin and their ratio to
total-adiponectin levels were significantly lower in full-
term than in preterm infants, but levels of LMW-adipo-
nectin and their proportion were higher. However,
HMW-adiponectin levels did not differ significantly
between full-term and preterm infants; they accounted
for almost 60% of total-adiponectin levels in both
groups. Total adiponectin levels were significantly lower
in preterm than in full-term infants, in agreement with pre-
vious studies w28x; this difference was probably due to
decreased adiposity of preterm infants. There is evidence
that circulating adiponectin levels correlate positively
with the degree of adiposity in neonates, but negatively
in adults w16, 24, 32x. The daily intake of dietary long-
chain polyunsaturated fatty acids that might have influ-
enced the total adiponectin levels w29x did not differ
significantly between the two infant groups (data not
shown). In addition, there was no difference in gender
distribution between groups. A sex dimorphism in cir-
culating adiponectin levels, with lower levels in males
than females, has been described in adulthood w20x, in
utero w6, 14x and in childhood, especially during the pro-
gression of puberty w1, 7, 22x, and has been attributed to
direct or indirect effects of sex hormones on adiponectin
secretion from adipocytes w1, 7, 11, 14, 20, 22x. However,
gender differences in adiponectin levels were not present
in several studies in neonates w10, 16, 24, 28, 32x and in
our study as well.
To our knowledge, all the three forms of adiponectin
multimers have been determined in both full-term and
preterm infants only in the recent study of Yoshida et al.
w35x. In that study, serum total adiponectin and its mul-
timers were measured in 46 preterm infants at birth and
at corrected term postmenstrual age, and in 26 full-term
infants at birth w35x. Serum concentrations of total-,
HMW-, MMW-, and LMW-adiponectin were significantly
greater in full-term than preterm infants at birth, but sim-
ilar to those of preterm infants at corrected term. The
ratio of HMW-adiponectin to total-adiponectin was
;60% in full-term newborns, in agreement with our find-
ings and with previous studies w12, 13, 21x. However, a
direct comparison of the results of the study of Yoshida
et al. w35x with ours cannot be done due to differences
in study population, especially regarding the postnatal
age and the anthropometric measurements of full-term
infants.
It is difficult to explain the meaning of the observed
differences in levels and proportions of MMW- and LMW-
adiponectin between preterm and full-term infants. It has
been shown that the distribution of adiponectin multi-
mers is influenced by environmental factors, such as
acidic conditions and concentrations of calcium, glu-
cose, and testosterone w5, 27, 34x, as well as genetic
factors, such as mutations of adiponectin associated
with impaired multimerization w33x. Adiponectin multimer
composition is affected by alterations in posttranslational
modifications of adiponectin in response to environmen-
tal factors during its production and/or secretion by adi-
pose tissue w25, 26x. However, once synthesized and
secreted, the adiponectin multimers circulate as bio-
chemically distinct and stable entities with little evidence
of interchange between the different forms w27x. In our
view, it would be interesting to ascertain whether the
pattern of adiponectin multimer distribution observed in
preterm infants reflects a particular distribution of adi-
ponectin multimers in fetal life before term and/or is relat-
ed to differences in subcutaneous or brown adipose
tissue between full-term and preterm infants w31x.
The physiological role of human adiponectin multimers
is of special interest. In previous studies in adults and
obese children, HMW-adiponectin has been reported to
correlate inversely with anthropometric measurements
(body weight or BMI, waist girth, visceral adipose tissue),
metabolic parameters (insulin and homeostasis model of
assessment of insulin resistance) and the development
of the metabolic syndrome better than plasma total adi-
ponectin levels w2, 9, 17x. In contrast, weak or absent
correlations between MMW- or LMW-adiponectin and
the above-mentioned parameters have been reported
w18, 19x. Thus, the effects of the MMW- and LMW-adi-
ponectin are still unclear, whereas HMW-adiponectin is
believed to be the primary active form having similar
biological roles to those recognized, so far, for total adi-
ponectin w2, 3, 9, 19x. In previous studies of HMW-
adiponectin in cord blood, it has been suggested that
HMW-adiponectin has a role on fetal or neonatal growth
because it correlated positively with neonatal anthropo-
metric parameters w12, 13x.
In our study, HMW-adiponectin did not correlate with
metabolic parameters (glucose, insulin), contrary to pre-
vious studies in older children and adults w2, 9, 17x but
in accordance with other studies in neonates w12, 32x.
HMW-adiponectin was the only multimer of adiponectin
exerting significant associations with the infants’ anthro-
pometric measurements and growth rates and the one
that correlated with the variables that total adiponectin
was associated with. Further studies are needed to elu-
cidate if HMW-adiponectin is indeed the active form of
adiponectin and to evaluate the biological role of MMW-
and LMW-adiponectin multimers in preterm and full-term
infants.
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